Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel
NCT01839968
·
clinicaltrials.gov ↗
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Acquired Platelet Disorder
Interventions
OTHER:
Ex vivo addition of normal platelet rich plasma to prasugrel-treated platelet rich plasma
Sponsor
University Hospital, Geneva